Global Context
For the foreseeable future, demand for healthcare services worldwide will continue to rise. It is therefore essential to find new ways to simultaneously increase both the efficiency and effectiveness of healthcare provision in the private and public sectors.
Our Solution
This is where Davion steps in. We have identified solutions that create value for investors, service providers, and patients through the research and development of innovative medical technologies. Our focus is on non-invasive home testing devices that allow individuals to quickly and easily monitor their health, providing rapid and early warnings of potential anomalies across a spectrum of medical conditions, including certain cancers.
These tests reduce the need for routine clinical visits, taking pressure off overburdened healthcare facilities. By harnessing technology, Davion brings detection tools into the home, making healthcare more accessible, increasing patient engagement, and enabling earlier detection. This shift not only enhances outcomes for patients but also reduces strain on public and private health systems.
Business Opportunity
Davion Healthcare develops cutting-edge, scientifically backed detection tools with a focus on non-invasive, at-home testing. By delivering self-test solutions directly, we streamline healthcare operations, lower costs, promote regular monitoring, and expand access, ultimately driving systemic change in how healthcare is delivered.
Our capital-light, licensing-led business model enables us to scale efficiently into new markets while maintaining lean operations. We are committed to organic growth and strategic acquisitions, expanding our portfolio to address the human health cycle comprehensively, including genetic, environmental, physical, and nutritional factors.
Our Commitment
With a global perspective and deep understanding of the challenges healthcare businesses face, Davion supports the delivery of effective and accessible medical services worldwide. Our Nasdaq listing underscores our mission to shift healthcare from clinics to homes—empowering patients with convenient, proactive tools for early detection and ongoing health management.
Products
BreastCheck
Breast cancer is the most common type of cancer in the UK, with more than 48,000 people diagnosed every year....
Read more
Innovative Home Medical Devices
Discover safe, easy-to-use medical solutions designed for comfort and convenience at home. Our devices help you take control of your health with confidence and peace of mind.
Growth Through Innovation & Acquisitions
We continue to expand by developing breakthrough technologies and strengthening our portfolio through strategic partnerships and acquisitions worldwide.
Board of Directors
Jack Kaye
Chairman
With over 45 years’ business experience, Jack established one of the first mobile phone network resellers in the UK, later acquired by Hutchison Whampoa.
Glenn Williams
Chief Executive Officer
Glenn Williams is a healthcare, finance and operations executive with more than 35 years of leadership across healthcare systems, pharma, and public markets.
Andreas Ttofi
Chief Financial Officer
Fully qualified ACCA Member with over a decade of leadership in audit, financial reporting, taxation, statutory accounts, and operational corporate finance.
Jeremy North
Chief Operating Officer
Senior executive across technology-led and innovation-driven businesses, with extensive expertise in corporate turnaround, M&A, and public company operations.
David Over
Chief Commercial Officer
Over 30 years of international leadership at the C-level for British and American enterprises, driving commercial transformation, marketing, and growth.
Sir Eric Peacock
Non-Executive Director
Chairman of IPro Sport Holdings Ltd, Buckley Jewellery Ltd, Stevenage Packaging Ltd, and Senior Non-Executive Director of Bango Plc.
Kevin Riches
Non-Executive Director
Proven background in starting, building, and selling companies across technology remanufacture, sales, mobile communications, and strategic business growth.
Susan M King
Non-Executive Director
Board Director, private investor and senior executive with extensive experience in global asset management, investment banking, and corporate oversight.
Julian F Sluyters
Non-Executive Director
Over 40 years of financial services leadership, serving as CEO and President for numerous mutual fund complexes in the United States and Europe.
Jan Dulman
Non-Executive Director
Seasoned CPA and audit professional with extensive Chief Financial Officer experience, leading SEC compliance, regulatory filings, and audit oversight.